[1]潘静薇,陆志刚,张佳胤,等. 冠状动脉介入治疗后迟发型对比剂肾病[J].介入放射学杂志,2013,(01):15-019.
　PAN Jing? wei,LU Zhi? gang,ZHANG Jia? yin,et al. Delayed contrast?蛳 induced nephropathy occurring after percutaneous coronary intervention[J].journal interventional radiology,2013,(01):15-019.
点击复制

 冠状动脉介入治疗后迟发型对比剂肾病 ()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2013年01期
页码:
15-019
栏目:
心脏介入
出版日期:
2013-01-25

文章信息/Info

Title:
 Delayed contrast?蛳 induced nephropathy occurring after percutaneous coronary intervention
作者:
 潘静薇;  陆志刚;  张佳胤;  宣昶有;  祁 晟;  汪年松;  魏 盟
Author(s):
 PAN Jing?蛳 wei;  LU Zhi?蛳 gang;  ZHANG Jia?蛳 yin;  XUAN Chang?蛳 you;  QI Sheng;  WANG Nian?蛳 song;  WEI Meng.
 Department of Cardiology， Shanghai Sixth People’s Hospital， Shanghai Jiaotong University， Shanghai 200233， China
关键词:
 ; 【关键词】 冠心病;  介入治疗;  肾功能不全;  碘克沙醇
文献标志码:
A
摘要:
 【摘要】 目的 观察等渗非离子型对比剂碘克沙醇对接受冠状动脉介入治疗（PCI）患者近期及远期肾功能的影响，探讨迟发型（> 1个月）对比剂肾病（delayed contrast induced nephropatholgy， DCIN）的诱因及危害。方法 观察2007年6月至2011年6月242例采用碘克沙醇行PCI治疗患者，根据PCI前24 h、PCI后2 ～ 3 d、1个月和3个月的血清肌酐水平，将患者分为对比剂肾病（CIN）组、DCIN组和肾功能无恶化组，评价多种危险因素与DCIN的相关性。结果 与PCI术后肾功能无恶化组（5.02 ± 1.64）相比，DCIN组和CIN组Mehran 危险积分显著升高（分别为6.72 ± 2.48 和6.97 ± 2.51），组间差异有统计学意义（P <0.001）；DCIN组和CIN组中，糖尿病、慢性肾功能不全、心功能不全等疾病伴发率显著增高（P < 0.05）；临床心血管事件率和全因死亡率显著增高（P < 0.05），但上述因素在CIN组和DCIN组间差异无统计学意义（P > 0.05）。结论 在PCI术前应用Mehran危险积分可以充分评估CIN风险。即使具有很好的肾脏耐受性，等渗对比剂同样需要注意术中用量。PCI术后长期监测患者肾功能与治疗前充分评估CIN风险同样重要。

参考文献/References:

 ［1］ Wi J， Ko YG， Kim JS， et al. Impact of contrast?蛳 induced acute kidney injury with transient or persistent renal dysfunction on long?蛳 term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention［J］. Heart， 2011， 97： 1753 ?蛳 1757.
［2］ Gurm HS， Dixon SR， Smith DE， et al. Renal function?蛳 based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions［J］. J Am Coll Cardiol， 2011， 58： 907 ?蛳 914.
［3］ Caruso M， Balasus F， Incalcaterra E， et al． Contrast?蛳 induced nephropathy after percutaneous coronary intervention in simple lesions： risk factors and incidence are affected by the definition utilized［J］． Intern Med， 2011， 50： 983 ?蛳 989．
［4］ Bolognese L， Falsini G， Schwenke C， et al. Impact of iso?蛳 osmolar versus low?蛳 osmolar contrast agents on contrast?蛳 induced nephropathy and tissue reperfusion in unselected patients with ST?蛳 segment elevation myocardial infarction undergoing primary percutaneous coronary intervention（from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction［CONTRAST?蛳 AMI］Trial）［J］. Am J Cardiol， 2012， 109： 67 ?蛳 74.
［5］ Shin DH， Choi DJ， Youn TJ， et al. Comparison of contrast?蛳 induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography［J］. Am J Cardiol， 2011， 108： 189 ?蛳 194.
［6］ Best PJ， Reddan DN， Berger PB， et al. Cardiovascular disease and chronic kidney disease： insights and an update［J］. Am Heart J， 2004， 148： 230 ?蛳 242.
［7］ Levy EM， Viscoli CM， Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis［J］. JAMA， 1996， 275： 1489 ?蛳 1494.
［8］ Mehran R， Aymong ED， Nikolsky E， et al. A simple risk score for prediction of contrast?蛳 induced nephropathy after percutaneous coronary intervention： development and initial validation［J］. J Am Coll Cardiol， 2004， 44： 1393 ?蛳 1399.
［9］ Briguori C， Airoldi F， D’andrea D， et al. Renal insufficiency following contrast media administration trial（REMEDIAL）： a randomized comparison of 3 preventive strategies［J］. Circula?蛳 tion， 2007， 115： 1211 ?蛳 1217.
［10］ Briguori C， Colombo A， Violante A， et al. Standard vs double dose of N?蛳 acetylcysteine to prevent contrast agent associated nephrotoxicity［J］. Eur Heart J， 2004， 25： 206 ?蛳 211.
［11］ Ng CS， Shaw AD， Bell CS， et al. Effect of Ⅳ contrast medium on renal function in oncologic patients undergoing CT in ICU［J］. Am J Roentgenol， 2010， 195： 414 ?蛳 422.
［12］ Liss P， Persson PB， Hansell P， et al. Renal failure in 57 925 patients undergoing coronary procedures using iso?蛳 osmolar or low?蛳 osmolar contrast media［J］. Kidney Int， 2006， 70： 1811 ?蛳 1817.
［13］ 张晓伟， 盛 力， 李 悦， 等． 不同类型造影剂对急性冠脉综合征患者PCI术后肾功能的影响［J］． 中国急救医学， 2012， 4： 357 ?蛳 359．
［14］ 倪靖炜， 沈卫峰， 张瑞岩， 等． 冠心病合并慢性肾功能不全患者的临床特征和PCI远期预后分析［J］． 介入放射学杂志， 2007， 16： 152 ?蛳 154．
［15］ Asim M， Jeffrey RF. Management of acute coronary syndrome in patients with chronic kidney disease： if we don’t risk anything， we risk even more［J］. Nephron Clin Pract， 2011， 119： c333 ?蛳 c336.
［16］ Budano C， Levis M， D’amico M， et al. Impact of contrast?蛳 induced acute kidney injury definition on clinical outcomes［J］. Am Heart J， 2011， 161： 963 ?蛳 971.
［17］ Maioli M， Toso A， Leoncini M， et al. Effects of hydration in contrast?蛳 induced acute kidney injury after primary angioplasty： a randomized， controlled trial［J］. Circ Cardiovasc Interv， 2011， 4： 456 ?蛳 462.
［18］ Brown JR， Malenka DJ， Devries JT， et al. Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention： insights from the Dartmouth Dynamic Registry［J］. Catheter Cardiovasc Interv， 2008， 72： 347 ?蛳 354.
［19］ 王 颖， 燕树勋， 史云菊． 血清光抑素C在老年人造影剂肾病中的评估作用［J］． 中国慢性病预防与控制， 2012， 2： 161 ?蛳 163．
［20］ Mehran R， Pocock S， Nikolsky E， et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient?蛳 level pooled analysis of the REPLACE?蛳 2（randomized evaluation of PCI linking angiomax to reduced clinical events），ACUITY（acute catheterization and urgent intervention triage strategy）， and HORIZONS?蛳 AMI（harmonizing outcomes with revascularization and stents in acute myocardial infarction）trials［J］. JACC Cardiovasc Interv， 2011， 4： 654 ?蛳 664.
［21］ Yoon HJ， Hur SH. Determination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrast?蛳 induced nephropathy after elective percutaneous coronary intervention［J］. Korean Circ J， 2011， 41： 265 ?蛳 271.
［22］ Liu Y， Tan N， Zhou YL， et al. The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast?蛳 induced nephropathy after primary percutaneous coronary intervention［J］. Int Urol Nephrol， 2012， 44： 221 ?蛳 229.
［23］ Patel K， King CA， Jovin IS. Angiotensin?蛳 converting enzyme inhibitors and their effects on contrast?蛳 induced nephropathy after cardiac catheterization or percutaneous coronary intervention［J］. Cardiovasc Revasc Med， 2011， 12： 90 ?蛳 93.
［24］ Sadat U. Contrast?蛳 induced nephropathy： do statins offer protection？［J］. Curr Opin Cardiol， 2011， 26： 334 ?蛳 337.

相似文献/References:

[1].Spontaneous regression of a giant basilar artery aneurysm in a young adult after surgical injury ：case report and literature review[J].介入放射学杂志,2007,(10):718.
　ZHANG He,LI Ming-hua,WANG Chun,et al.Spontaneous regression of a giant basilar artery aneurysm in a young adult after surgical injury ：case report and literature review[J].journal interventional radiology,2007,(01):718.
[2]李统怀,郑红枫. 子宫动脉栓塞治疗子宫瘢痕妊娠１１例[J].介入放射学杂志,2011,(11):898.
　LI Tong-huai,ZHENG Hong-feng..Clinical application of uterine artery embolization in treating uterine scar pregnancy[J].journal interventional radiology,2011,(01):898.
[3]吕维富,张爱武,周春泽,等. 子宫动脉的三维DSA表现及其最佳显示体位探讨[J].介入放射学杂志,2011,(11):853.
　LV Wei-fu,ZHANG Ai-wu,ZHOU Chun-ze,et al.3D-DSA findings of uterine artery and its optimal projection position[J].journal interventional radiology,2011,(01):853.
[4]张 靖,周少毅,陈昆山,等.经导管动脉硬化栓塞联合注射硬化治疗婴儿颌面部巨大高流量血管瘤[J].介入放射学杂志,2011,(11):848.
　ZHANG Jing,ZHOU Shao-yi,CHEN Kun-shan,et al.Transcatheter arterial sclerosing embolization with injection sclerotherapy for the treatment of huge and high-flow maxillofacial hemangiomas in infants[J].journal interventional radiology,2011,(01):848.
[5]谢小西,吕银祥,章宏欣,等. 肝动脉化疗栓塞、射频消融联合１２５Ⅰ粒子植入 治疗原发性肝癌的临床应用[J].介入放射学杂志,2011,(11):863.
　XIE Xiao-xi,LV Yin-xiang,ZHANG Hong-xin,et al.The clinical application of TACE together with RFA and 125Ⅰ seed implantation in treating hepatocellular carcinoma[J].journal interventional radiology,2011,(01):863.
[6]王铭义,王 峰. 脑灌注成像在颈动脉狭窄介入治疗中的应用[J].介入放射学杂志,2011,(11):915.
　WANG Ming-yi,WANG Feng..Application of brain perfusion imaging in interventional treatment of carotid artery stenosis[J].journal interventional radiology,2011,(01):915.
[7]杜 猛,张锦生. 介入治疗急性深静脉血栓的临床观察[J].介入放射学杂志,2011,(11):858.
　DU Meng,ZHANG Jing-sheng..Interventional therapy for acute deep venous thrombosis: a clinical observation[J].journal interventional radiology,2011,(01):858.
[8]孟庆娜,李国庆,白晓冬. 急性心肌梗死介入治疗术中恶心呕吐的护理[J].介入放射学杂志,2011,(11):913.
　MENG Qing-na,LI Guo-qing,BAI Xiao-dong..The nursing care of nausea and vomiting occurred in interventional treatment for acute myocardial infarction[J].journal interventional radiology,2011,(01):913.
[9]王海亭,蒋忠仆,周 毅,等. 透视引导下鱼肝油酸钠泡沫硬化剂治疗下肢静脉曲张３０例[J].介入放射学杂志,2011,(11):905.
　WANG Hai-ting,JIANG Zhong-pu,ZHOU Yi,et al.Fluoroscopically-guided foam sclerotherapy with sodium morrhuate for the treatment of lower extremity varices[J].journal interventional radiology,2011,(01):905.
[10]杜 鲲,管 生,胡小波,等. 原发性肝癌ＴＡＣＥ术后完全缓解病灶磁共振 ＡＤＣ值可重复性及一致性研究[J].介入放射学杂志,2011,(11):867.
　DU Kun,GUAN Sheng,HU Xiao-bo,et al.Magnetic resonance apparent diffusion coefficient values of the completely remitted lesions of primary hepatocellular carcinoma after TACE: a study of their repeatability and consistency[J].journal interventional radiology,2011,(01):867.
[11]戴 煌,秦永文,萧 毅.320排动态容积CT冠状动脉成像诊断冠心病的初步应用[J].介入放射学杂志,2012,(07):541.
　DAI Huang,QIN Yong- wen,XIAO Yi.. Preliminary application of 320-detector row dynamic volume CT angiography in diagnosing coronary heart diseases[J].journal interventional radiology,2012,(01):541.
[12]罗育坤,范 林,林朝贵,等. 破裂斑块行介入治疗对冠状动脉血流的影响[J].介入放射学杂志,2012,(11):898.
　LUO Yu-kun,FAN Lin,LIN Chao- gui,et al. Changes of coronary flow occurred after percutaneous coronary intervention for ruptured plaque detected by intravascular ultrasound[J].journal interventional radiology,2012,(01):898.
[13]王智廷,曹国全,闻彩云,等. 冠状动脉介入治疗中操作者所受剂量的综合研究[J].介入放射学杂志,2013,(10):834.
　WANG Zhi? ting,CAO Guo? quan,WEN Cai? yun. HUANG Zhou? qing.. The radiation dose to operators in performing percutaneous coronary intervention： a comprehensive study[J].journal interventional radiology,2013,(01):834.

备注/Memo

备注/Memo:
 （收稿日期：２０１2-０7-25）
更新日期/Last Update: